- Bagged the 2021 South Asia Silver Award with a successful sales performance achievement (107.20%) and growth (137.90%) over countries in South Asia (Thailand, Malaysia, Singapore, Hong Kong, Taiwan, Vietnam, and Sri Lanka).- Illustrated a competitive result as the assigned territory acquired a year-to-date sales achievement of 107.20% vs. budget and generated a triple-digit growth of 137.90% in 2021. - Managed to successfully bag a 121% marketing activities implementation rate and ended at an 186% SFE KPI achievement in 2021. - Gained a "successful" rating and finished with a 90% qualitative and quantitative overall KPI achievement in 2021.- Collaborated with the Advantan® Task Force and successfully launched a new brand in November 2021, which led to an increase in HCP brand awareness, sales team readiness, and strong trade pipelining.

- Managed to achieve 91% MCCP reach in December and January 2021. - Efficiently gained market share in both handled brands vs. competitors. - Effectively engaged healthcare professionals through PFSS and multi-channel selling approach aligned to their preferences.

- Led a team handling Manila, Quezon City, and North Luzon. - Handled key accounts for aesthetic lines, specifically Botulinum toxin and Hyaluronic acid fillers.

- The first-ever professional medical representative in the organization who consistently achieved year-to-date sales from 2017 to 2019. - Managed to achieve year-to-date sales vs. budget in 2019 across all focused principals, namely Good Pharma Dermatology Philippines (120.64%), GSK Consumer (148%.03%), GSK Pharma (154.95%), and Nurturemed Philippines (316.37%). - Contributed 24.89% shares to the sales team and maintained an 83% re-order rate in 2019. - Spearheaded several round-table-discussions, continuing medical education, and workshops that led to an 83% increase in growth in 2019.